Mirae Asset Global Investments Co., Ltd. Pliant Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,801 shares of PLRX stock, worth $22,512. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,801Holding current value
$22,512% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding PLRX
# of Institutions
158Shares Held
63.8MCall Options Held
481KPut Options Held
105K-
Deep Track Capital, LP Greenwich, CT5.97MShares$74.7 Million2.11% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$62.1 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.6MShares$57.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$43 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN3.4MShares$42.5 Million3.33% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $609M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...